Ropivacaine Hydrochloride
- Product NDC
- 70518-2681
- 11-digit product format
- 705182681
- Labeler code
- 70518
- Product ID
- 70518-2681_dc8b1619-388c-02d2-e053-2995a90af8ac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ropivacaine Hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- EPIDURAL; INFILTRATION; PERINEURAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA205612
- Marketing category
- ANDA
- Marketing start
- 2020-04-08
- Marketing end
- 0000-00-00
- Substance
- ROPIVACAINE HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2681-0 | 70518268100 | 25 VIAL, SINGLE-DOSE in 1 CARTON (70518-2681-0) > 20 mL in 1 VIAL, SINGLE-DOSE (70518-2681-1) | 2020-04-08 | 0000-00-00 | No | No | Current |